DOI QR코드

DOI QR Code

Antioxidative, Anti-inflammatory Effects of Jibaekjihwang-tang (zhibaidihuang-tang) on Osteoarthritic Rat Model

지백지황탕(知栢地黃湯)의 골관절염 Rat 모델에 대한 항산화, 항염증 효과

  • Woo, Chang-Yun (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Daegu Haany University) ;
  • Kim, Young-Jun (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Daegu Haany University) ;
  • Woo, Chang-Hoon (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Daegu Haany University)
  • 우창윤 (대구한의대학교 한의과대학 한방재활의학과교실) ;
  • 김영준 (대구한의대학교 한의과대학 한방재활의학과교실) ;
  • 우창훈 (대구한의대학교 한의과대학 한방재활의학과교실)
  • Received : 2020.03.17
  • Accepted : 2020.04.06
  • Published : 2020.04.30

Abstract

Objectives This study intended to evaluate antioxidative, anti-inflammatory effects of Jibaekjihwang-tang on monosodium iodoacetate (MIA)-induced osteoarthritic rat model and investigate the potential mechanism. Methods Jibaekjihwang-tang (100 or 200 mg/kg body weight) was orally administered once daily for 2 weeks days from day 7 after intra-articular MIA injection. And blood analysis, the histologic examinations were performed. Moreover, protein expressions related to anti-oxidant and cartilage degradation and anti-inflammatory cytokines were measured by western blot analysis in cartilaginous tissue. Results Jibaekjihwang-tang reduced serum inflammatory cytokines such as tumor necosis factors-α and interleukin-6. Furthermore, the increase of anti-oxidant enzymes reversed the oxidative stress caused by MIA. Meanwhile, Jibaekjihwang-tang suppressed MIA-induced inflammation and cartilage degradation in cartilaginous tissue. Conclusions Jibaekjihwang-tang alleviated MIA-induced inflammation. Jibaekjihwang-tang was associated with a protective effect on cartilage and by reducing inflammation and cartilage degradation. These findings provide new approaches for understanding osteoarthritis therapy.

Keywords

References

  1. The Korean Orthopaedic Association. Orthopaedics. 7th ed. Seoul:ChoiSin medical Publishing Co. 2013:290, 292, 317, 321.
  2. The Society of Korean Medicine Rehabilitation. Korean rehabilitation medicine. 4th ed. Paju:Koonja Publishing. 2015:102-16.
  3. Yoh SB, Sul JU, Shin MS. Research trends on the treatment of knee osteoarthritis in Korean medicine. The Korean Journal of Acupuncture. 2011;28(1):139-55.
  4. Oh K. Euijongguemgam. Seoul:Daesung MoonWha Inc. 1983:49-51.
  5. Lee GH, Yoo DY. Evaluation of anti-inflammatory effects of yukmijihwangtang and individual drug substances based on the extraction methods. J Korean Obstet Gynecol. 2012;25(2):89-107. https://doi.org/10.15204/JKOBGY.2012.25.2.089
  6. Lee YK, Kim CT, Choi HJ. Anti-inflammatory effect of anemarrhenae rhizoma 80% ethanol extract in RAW 264.7 cells. Kor J Herbol. 2017;32(3):97-103. https://doi.org/10.6116/kjh.2017.32.3.97
  7. Jang JH, Kim KS, Kim CH. $1{\beta}$ inhibitory effect on the expression - yellowish and above the youngseon acupuncture Lipopolysaccharide-induced arthritis in the IL: Literature study. J Acupunct Res. 1999;16(1):511-31.
  8. Yun YK. Donguibangje and cheobanghaeseol. Seoul: Uiseongdang. 1998:336-7.
  9. Hatano T, Edamatsu R, Hiramatsu M, Mori A, Fujita Y, Yasuhara T, Yoshida T, Okuda T. Effects of the interaction of tannins with co-existing substances. VI. Effects if tannins and related polyphenols on superoxide anion radical, and 1,1-diphenyl-2-picrylhydrazyl radical. Chem Pharm Bull. 1989;37(8):2016-21. https://doi.org/10.1248/cpb.37.2016
  10. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26(9-10):1231-7. https://doi.org/10.1016/S0891-5849(98)00315-3
  11. Folin O, Denis W. On phosphotungasticphosphomolybdic compounds as color reagents. J Biol Chem. 1912; 12(2):239-43. https://doi.org/10.1016/S0021-9258(18)88697-5
  12. Lister CE, Lancaster JE, Sutton KH, Walker JR. Developmental changes in the concentration and composition of flavonoids in skin of a red and a green apple cultivar. Journal of the Science of Food and Agriculture. 1994;64(2):155-61. https://doi.org/10.1002/jsfa.2740640204
  13. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271-8. https://doi.org/10.1016/0003-2697(78)90342-1
  14. Shim YS, Jeon MK, Kim KS, Sohn IC. Effects of Aqua-acupuncture of jibaikjihwangtang on the blood pressure in hypertensive rats. J Acupunct Res. 2004; 21(4):1-18.
  15. Lee SH, Kim DC. Aqueous extracts of jibaekjihwang-tang ameliorate ovariectomy-induced climacterium symptoms in mouse. J Korean Obstet Gynecol. 2017;30(2):16-36. https://doi.org/10.15204/jkobgy.2017.30.2.016
  16. Kim HJ, Kim TY, Lee CH, Kim CH. A case report of progressive pigmented purpuric dermatosis improved with jibaekjihwang-tang. The Korean Medicine Opthalmology&Otolaryngology&Dermatology Society. 2013;26(2):109-16.
  17. Korean Herbalogy Society. Herbalogy. Seoul:Young-lim. 2016:201, 221, 235, 345, 348, 581, 633, 688.
  18. Jung YS, Kang HW, Lyu YS. Studies on the anti-inflammatory action of teamed Rehmannia glutinosa in central nervous system. J of Oriental Neuropsychiatry. 1999;10(2):59-70.
  19. Kim MJ, Park HJ, Kim KJ, Lee JA, Shin MR, Roh SS. Protective effect of dioscoreae rhizoma extracts in MIA-induced rat. Kor J Herbol. 2019;34(4):27-35. https://doi.org/10.6116/KJH.2019.34.4.27
  20. Oh MS, Kim DR, Sung EJ, Chang MS, Park SK. Antioxidant effects of corni fructus in GC-1 cells. Korean J Oriental Physiology & Pathology. 2005;19(6):1541-5.
  21. Rios JL. Chemical constituents and pharmacological properties of Poria cocos. Planta Med. 2011;77(7):681-91. https://doi.org/10.1055/s-0030-1270823
  22. Yu JH. Overview for Studies on Alismatis Rhizoma in the Korean literatures [dissertation]. Iksan:Wonkwang University; 2012.
  23. Kim DH, Song BK, Kim HK. Effect of moutan radicis cortex on collagen-induced arthritis. The Journal of Traditional Korean Medicine. 1997;7(2):60-9.
  24. Kalben DA, Blum U. Hypothesis and experimental confirmation of a new pharmacological model of osteoarthrosis. Arzneimittelforschung. 1977;27(3):527-31.
  25. Combe R, Bramwell S, Field MJ. The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats? Neurosci Lett. 2004;370(2-3):236-40. https://doi.org/10.1016/j.neulet.2004.08.023
  26. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol. 2003;31(6):619-24. https://doi.org/10.1080/01926230390241800
  27. Song YJ, Ha CW. The use of COX-2 selective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis. J Korean Knee Soc. 2009;21(2):84-92.
  28. Cho YJ, Moon SL, Park KH, Cho NC, Song YW. Comparison of side effects of non-steroidal antiinflammatory drugs(NSAIDs) in rheumatoid arthritis patients. J Kor Soc Hosp Pharm. 1998;15(2):186-92.
  29. Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R. The protective role of ROS in autoimmune disease. Trends Immunol. 2009;30(5):201-8. https://doi.org/10.1016/j.it.2009.03.004
  30. Dang PM, Cross AR, Babior BM. Assembly of the neutrophil respiratory burst oxidase: A direct interaction between $p67^{phox}$ and cytochrome b558. Proc Natl Acad Sci USA. 2001;98(6):3001-5. https://doi.org/10.1073/pnas.061029698
  31. Radermacher KA, Wingler K, Kleikers P, Altenhofer S, Jr Hermans J, Kleinschnitz C, Hhw Schmidt H. The 1027th target candidate in stroke: Will NADPH oxidase hold up? Exp Transl Stroke Med. 2012;4(1):1-11. https://doi.org/10.1186/2040-7378-4-1
  32. Van Raamsdonk JM, Hekimi S. Superoxide dismutase is dispensable for normal animal lifespan. Proc Natl Acad Sci USA. 2012;109(15):5785-90. https://doi.org/10.1073/pnas.1116158109
  33. Preiser JC. Oxidative stress. JPEN J Parenter Enteral Nutr. 2012;36(2):147-54. https://doi.org/10.1177/0148607111434963
  34. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179(4073):588-90. https://doi.org/10.1126/science.179.4073.588
  35. Park SH, Lee HJ, Ryu JH, Lee SY, Shin HD, Hong JH, Seok JH, Lee CJ. Effects of silibinin and resveratrol on degradation of $I{\kappa}B$ and translocation of NF-${\kappa}B$ p65 induced by tumor necrosis factor-$\alpha$ in cultured airway epithelial cells. J Pharm. 2014;58(1):1-6.
  36. Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007;40(2):251-64. https://doi.org/10.1016/j.bone.2006.09.023
  37. Rodriguez-Carballo E, Gamez B, Ventura F. p38 MAPK signaling in osteoblast differentiation. Front Cell Dev Biol. 2016;4:40.
  38. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2003;2(9):717-26. https://doi.org/10.1038/nrd1177
  39. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-${\kappa}B$p65 transactivation mediated by tumor necrosis factor. J Biol Chem. 1998;273(6):3285-90. https://doi.org/10.1074/jbc.273.6.3285
  40. Saha RN, Jana M, Pahan K. MAPK p38 regulates transcriptional activity of NF-${\kappa}B$ in primary human astrocytes via acetylation of p65. J Immunol. 2007;179(10):7101-9. https://doi.org/10.4049/jimmunol.179.10.7101
  41. Brune K, Hinz B. Selective cyclooxygenase-2 inhibitors: similarities and differences. Scand J Rheumatol. 2004;33(1):1-6. https://doi.org/10.1080/03009740310004766
  42. Abramson SB. Osteoarthritis and nitric oxide. Osteoarthritis Cartilage. 2008;16(2):15-20. https://doi.org/10.1016/S1063-4584(08)60008-4
  43. Sakaguchi Y, Shirahase H, Ichikawa A, Kanda M, Nozaki Y, Uehara Y. Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice. Life Sci. 2004;75(19):2257-67. https://doi.org/10.1016/j.lfs.2004.02.037
  44. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861-74. https://doi.org/10.1016/S0140-6736(07)60784-3
  45. Iking-Konert C, Bartz-Bazzanella P, Falagan D, Hofman MW, Schwarting A, Dorner T. Interleukin-6 inhibition as a potential therapeutic target in rheumatic diseases. Z Rheumatol. 2014;73(3):269-76. https://doi.org/10.1007/s00393-013-1268-9
  46. Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, Yao Y. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141(2):125-39. https://doi.org/10.1016/j.pharmthera.2013.09.004
  47. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18(5):1135-49. https://doi.org/10.1200/JCO.2000.18.5.1135
  48. Lambert E, Dasse E, Haye B, Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004;49(3):187-98. https://doi.org/10.1016/j.critrevonc.2003.09.008
  49. Lee SH, Kwon KD, Lee SW, Cho SH, Ahn HS. Acetabular degeneration in osteonecrosis of the femoral head. J of Korean Orthop Assoc. 2004;39(3):239-46. https://doi.org/10.4055/jkoa.2004.39.3.239
  50. Dijkgraaf LC, de Bont LG, Boering G, Liem RS. Normal cartilage structure, biochemistry, and metabolism: a review of the literature. J Oral Maxillofac Surg. 1995;53(8):924-9. https://doi.org/10.1016/0278-2391(95)90283-X